[关键词]
[摘要]
目的 探究桃红四物汤(Taohong Siwu Decoction,TSD)在制剂过程中11个主要成分与抗凝血生物活性的传递规律及其动态关联。方法 制备15批次TSD的4个制剂单元样品(水煎液、浓缩液、基准样品、颗粒剂),采用UPLC同步测定各制剂单元中11个主要成分(没食子酸、地黄苷D、川芎嗪、苦杏仁苷、绿原酸、芍药苷、羟基红花黄色素A、阿魏酸、槲皮素、佛手柑内酯、山柰酚)含量,计算其在制剂过程中的传递率;同时,以凝血酶时间(thrombin time,TT)为指标测定TSD抗凝血生物效价,计算生物活性保留率,计算其在制剂过程中的传递率;并运用随机森林(random forest,RF)模型分析11个主要成分对其抗凝血生物活性的预测贡献。结果 11个主要成分含量的批次间波动基本控制在±30%以内,在水煎液-浓缩液阶段平均转移率为44.85%~81.81%,浓缩液-基准样品阶段平均转移率为76.63%~89.21%,基准样品-颗粒剂阶段平均转移率为86.79%~93.69%。同时,抗凝血生物活性在3个阶段的平均保留率分别为93.75%、94.23%和91.05%。RF模型显示主要成分含量与抗凝血生物活性关联模型(R2=0.900 6)在不同制剂单元间具有较好的稳定性(R2=0.647 2~0.812 8)。结论 TSD制剂过程中11个主要成分与其抗凝血生物活性稳定传递,为其生产过程质量控制与标准制定提供科学依据。
[Key word]
[Abstract]
Objective To explore the transfer patterns and dynamic correlations of 11 major constituents and the anticoagulant bioactivity of Taohong Siwu Decoction (TSD, 桃红四物汤) during the formulation process. Methods Four formulation units (decoction, concentrated solution, referencesamples, and granules) from 15 batches of TSD were prepared, and UPLC was used to simultaneously determine the contents of 11 components (gallic acid, rehmannioside D, tetramethylpyrazine, amygdalin, chlorogenic acid, paeoniflorin, hydroxysafflor yellow A, ferulic acid, quercetin, bergapten, kaempferol), and their transfer rates during the formulation process were calculated. Furthermore, the anticoagulant bioactivity was determined using thrombin time (TT) as an indicator, the bioactivity retention rate was calculated, and the transfer rate during the formulation process was determined. A random forest (RF) model was also used to analyze the predictive contribution of the 11 major constituents to anticoagulant bioactivity.. Results Batch-to-batch variations in the concentrations of the 11 components were generally maintained within ± 30%. The average transfer rate in the decoction-concentrate stage ranged from 44.85% to 81.81%, and in the concentrate-reference sample stage, it ranged from 76.63% to 89.21%. and the average transfer rate in the reference sample to granules stage was 86.79%—93.69%. Furthermore, the average retention rates of anticoagulant activity across the three stages were 93.75%, 94.23%, and 91.05%. The RF model showing the correlation between constituent contents and anticoagulant bioactivity (R2 = 0.900 6) demonstrated good stability across different formulation batches (R2 = 0.647 2—0.812 8). Conclusion During the preparation of TSD, the 11 major constituents and their anticoagulant bioactivity were stably transferred, providing a scientific basis for quality control and the establishment of standards in the production process.
[中图分类号]
R283.6
[基金项目]
四川省自然科学基金项目(2024NSFSC0696)